Bloomberg -- AstraZeneca Plc, the U.K.’s second- biggest drugmaker, fell the most in almost nine months in London trading after saying fourth-quarter comparisons would be “demanding” as generic competition cuts into profit.
Bloomberg -- AstraZeneca Plc, the U.K.’s second- biggest drugmaker, fell the most in almost nine months in London trading after saying fourth-quarter comparisons would be “demanding” as generic competition cuts into profit.
